© Copyright 2026 American Medical Association. All rights reserved.
Intracutaneous (intradermal) tests are diagnostic procedures used to assess an individual's sensitivity to specific allergens. These tests involve the administration of allergenic extracts, which are substances derived from potential allergens, injected just beneath the surface of the skin. The primary purpose of these tests is to provoke a delayed type allergic reaction, which typically manifests over a period of several days. During the procedure, one or more allergenic extracts are carefully selected and documented, ensuring that the specific allergens being tested are clearly identified. Patients are provided with detailed instructions regarding the expected outcomes of a delayed type reaction, including the timeline for when they should return for evaluation. Generally, patients are asked to return to the healthcare facility approximately 48 hours after the initial injection. At this follow-up visit, a physician or qualified healthcare professional examines the injection sites to assess for any signs of allergic reactions, such as redness, swelling, or inflammation. The results of the test are then interpreted, and a comprehensive written report is generated, detailing the presence, absence, or degree of allergic reaction to each allergen tested. This structured approach ensures that the testing process is thorough and that the results are clearly communicated to the patient and relevant healthcare providers.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.